Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitors
Wesam S. Ahmed, Anupriya M. Geethakumari, Kabir H. Biswas
Biomedicine & Pharmacotherapy (2020) Vol. 134, pp. 111128-111128
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 4, pp. 293-859
Open Access | Times Cited: 221
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
Letizia Crocetti, Giuseppe Floresta, Agostino Cilibrizzi, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4964-4964
Open Access | Times Cited: 74
Oxidative Stress and Erectile Dysfunction: Pathophysiology, Impacts, and Potential Treatments
Aris Kaltsas, Athanasios Zikopoulos, Fotios Dimitriadis, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8807-8834
Open Access | Times Cited: 17
Management of erectile dysfunction
Natalie Schellack, Gustav Schellack, NA Nyane
SA pharmaceutical journal. (2025) Vol. 92, Iss. 2, pp. 19-26
Closed Access | Times Cited: 2
Defining proteoform-specific interactions for drug targeting in a native cell signalling environment
Corinne A. Lutomski, Jack L. Bennett, Tarick J. El‐Baba, et al.
Nature Chemistry (2025)
Open Access | Times Cited: 2
Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2
Angelin M. Philip, Wesam S. Ahmed, Kabir H. Biswas
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1966-1977
Open Access | Times Cited: 27
The role of the methoxy group in approved drugs
Debora Chiodi, Yoshihiro Ishihara
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116364-116364
Closed Access | Times Cited: 14
Pathophysiology and therapeutic options for cirrhotic portal hypertension
Sergi Guixé‐Muntet, Sergio Quesada‐Vázquez, Jordi Gracia‐Sancho
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 7, pp. 646-663
Closed Access | Times Cited: 10
Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021
C Michael White
The Journal of Clinical Pharmacology (2022) Vol. 62, Iss. 8, pp. 928-934
Closed Access | Times Cited: 37
Advances in dual-targeting inhibitors of HDAC6 for cancer treatment
Zhicheng Gu, Shuxian Lin, Junhui Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116571-116571
Closed Access | Times Cited: 6
Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease
Jianwen Sheng, Shanjin Zhang, Lule Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia
Tiewen Li, Yu Zhang, Zeng Zhou, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Structure-based method for the discovery of selective inhibitors of PED 5 in erectile dysfunction therapy from the Pacific oyster peptides (Crassostrea gigas): Peptidomic analysis, molecular docking, and activity validation
Jianhui Feng, Wenhao Cao, Bo Xu, et al.
International Journal of Biological Macromolecules (2025) Vol. 295, pp. 139494-139494
Closed Access
Unlocking the potential of photobiomodulation therapy for brain neurovascular coupling: The biological effects and medical applications
Bingzi Yan, Jie Zhou, F. Yan, et al.
Journal of Cerebral Blood Flow & Metabolism (2025)
Open Access
Advances in the development of phosphodiesterase 5 inhibitors
Tieqiang Zong, Xing Huang, Wei Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117365-117365
Closed Access
Rational Design and Optimization of Novel PDE5 Inhibitors for Targeted Colorectal Cancer Therapy: An In Silico Approach
Samson Marvellous Oladeji, Deborah Ngozi Conteh, Lukman Abidemi Bello, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1937-1937
Open Access
Comparison of PDE-5 inhibitors used in erectile dysfunction with some candidate molecules: A study involving molecular docking, ADMET, DFT, biological target, and activity
Süleyman Sağır, Velid Ünsal, Erkan Öner, et al.
BMC Urology (2025) Vol. 25, Iss. 1
Open Access
ANROFRC Enables Skeletal Editing of 4-Arylpyrimidines into Diverse Nitrogen Heteroaromatics
Haiyan Fu, Shun Li, Yonglin Shi, et al.
Research Square (Research Square) (2025)
Closed Access
Phosphodiesterase 5 inactivation in vascular smooth muscle cells aggravates aortic aneurysm and dissection
Yuyao Feng, Yunfei Xue, Xiaohang Feng, et al.
The Journal of Pathology (2025)
Open Access
Efficacy of topical sildenafil formulations in enhancing wound healing outcomes: a narrative review
Maryam Shahrokhi, Fatemeh Naghibi, Sabah Moraghebi, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Evaluation of the acute effects of single‐dose TPN171 on semen quality in healthy Chinese male volunteers
Yuzhuo Yang, Zhe Zhang, P. R. Li, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
Investigation of PDE5 effect on NOS in nasal polyp pathophysiology
Vahit Mutlu, Zülküf Kaya, Zekai Halıcı, et al.
European Archives of Oto-Rhino-Laryngology (2025)
Open Access
Coevolving residues distant from the ligand binding site are involved in GAF domain function
Wesam S. Ahmed, Anupriya M. Geethakumari, Asfia Sultana, et al.
Communications Chemistry (2025) Vol. 8, Iss. 1
Open Access
Phosphodiesterase‑5 inhibitors and Alzheimer’s disease; a meta‑analysis on clinical studies
Saman Behboodi Tanourlouee, Parham Torabinavid, Ali Vaezi, et al.
(2025) Vol. 1, Iss. 1
Open Access
Simultaneous determination of four PDE5 inhibitors and metabolites in rat plasma by UPLC-MS/MS
Xiaonan Xia, Zhe Song, Weidong He, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116883-116883
Closed Access
Page 1 - Next Page

Scroll to top